157 related articles for article (PubMed ID: 16030158)
1. Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma.
Landriscina M; Fabiano A; Altamura S; Bagalà C; Piscazzi A; Cassano A; Spadafora C; Giorgino F; Barone C; Cignarelli M
J Clin Endocrinol Metab; 2005 Oct; 90(10):5663-71. PubMed ID: 16030158
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of the therapeutic potential of nevirapine in treatment of human thyroid anaplastic carcinoma.
Dong JJ; Zhou Y; Liu YT; Zhang ZW; Zhou XJ; Wang HJ; Liao L
Mol Cell Endocrinol; 2013 May; 370(1-2):113-8. PubMed ID: 23462194
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin dependent and independent thyroid cell lines selected from FRTL-5 derived tumors grown in nude mice.
Ossendorp FA; Bruning PF; Schuuring EM; Van Den Brink JA; van der Heide D; De Vijlder JJ; De Bruin TW
Endocrinology; 1990 Jul; 127(1):419-30. PubMed ID: 1694496
[TBL] [Abstract][Full Text] [Related]
4. Targeting epidermal growth factor receptor 1 signaling in human thyroid-stimulating hormone-independent thyroid carcinoma FRO cells results in a more chemosensitive and less angiogenic phenotype.
Landriscina M; Piscazzi A; Fabiano A; Maddalena F; Costantino E; Farese A; Bufo P; Cignarelli M
Thyroid; 2009 Jun; 19(6):629-37. PubMed ID: 19499990
[TBL] [Abstract][Full Text] [Related]
5. Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma.
Landriscina M; Altamura SA; Roca L; Gigante M; Piscazzi A; Cavalcanti E; Costantino E; Barone C; Cignarelli M; Gesualdo L; Ranieri E
Int J Cancer; 2008 Jun; 122(12):2842-50. PubMed ID: 18351578
[TBL] [Abstract][Full Text] [Related]
6. Reinduction of cell differentiation and 131I uptake in a poorly differentiated thyroid tumor in response to the reverse transcriptase (RT) inhibitor nevirapine.
Modoni S; Landriscina M; Fabiano A; Fersini A; Urbano N; Ambrosi A; Cignarelli M
Cancer Biother Radiopharm; 2007 Apr; 22(2):289-95. PubMed ID: 17600478
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene.
Lee YJ; Chung JK; Shin JH; Kang JH; Jeong JM; Lee DS; Lee MC
Thyroid; 2004 Nov; 14(11):889-95. PubMed ID: 15671766
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of thyroid hormone receptor beta1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line.
Chen ST; Shieh HY; Lin JD; Chang KS; Lin KH
J Endocrinol; 2000 May; 165(2):379-89. PubMed ID: 10810302
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin.
Furuya F; Shimura H; Suzuki H; Taki K; Ohta K; Haraguchi K; Onaya T; Endo T; Kobayashi T
Endocrinology; 2004 Jun; 145(6):2865-75. PubMed ID: 14976143
[TBL] [Abstract][Full Text] [Related]
10. Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo.
Landriscina M; Bagalà C; Piscazzi A; Schinzari G; Quirino M; Fabiano A; Bianchetti S; Cassano A; Sica G; Barone C
Prostate; 2009 May; 69(7):744-54. PubMed ID: 19152342
[TBL] [Abstract][Full Text] [Related]
11. Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter.
Hsieh YJ; Ke CC; Liu RS; Wang FH; Tang KT; Chi CW; Chen FD; Lee CH
Anticancer Res; 2007; 27(4B):2515-22. PubMed ID: 17695547
[TBL] [Abstract][Full Text] [Related]
12. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
[TBL] [Abstract][Full Text] [Related]
13. Capsaicin restores sodium iodine symporter-mediated radioiodine uptake through bypassing canonical TSH‒TSHR pathway in anaplastic thyroid carcinoma cells.
Xu S; Cheng X; Wu J; Wang Y; Wang X; Wu L; Yu H; Bao J; Zhang L
J Mol Cell Biol; 2022 Jan; 13(11):791-807. PubMed ID: 34751390
[TBL] [Abstract][Full Text] [Related]
14. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.
Moretti F; Farsetti A; Soddu S; Misiti S; Crescenzi M; Filetti S; Andreoli M; Sacchi A; Pontecorvi A
Oncogene; 1997 Feb; 14(6):729-40. PubMed ID: 9038381
[TBL] [Abstract][Full Text] [Related]
15. Iodide uptake in human anaplastic thyroid carcinoma cells after transfer of the human thyroid peroxidase gene.
Haberkorn U; Altmann A; Jiang S; Morr I; Mahmut M; Eisenhut M
Eur J Nucl Med; 2001 May; 28(5):633-8. PubMed ID: 11383870
[TBL] [Abstract][Full Text] [Related]
16. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
Zito G; Richiusa P; Bommarito A; Carissimi E; Russo L; Coppola A; Zerilli M; Rodolico V; Criscimanna A; Amato M; Pizzolanti G; Galluzzo A; Giordano C
PLoS One; 2008; 3(10):e3544. PubMed ID: 18958156
[TBL] [Abstract][Full Text] [Related]
17. [Influences of nevirapine on cell proliferation and expression of sodium/iodide symporter in human anaplastic thyroid carcinoma cell line].
Zhou Y; Dong JJ; Wang HJ; Zhang ZW; Liao L
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(12):811-3. PubMed ID: 22781452
[TBL] [Abstract][Full Text] [Related]
18. The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells.
Bauriaud-Mallet M; Vija-Racaru L; Brillouet S; Mallinger A; de Medina P; Rives A; Payre B; Poirot M; Courbon F; Silvente-Poirot S
J Steroid Biochem Mol Biol; 2019 Sep; 192():105390. PubMed ID: 31170473
[TBL] [Abstract][Full Text] [Related]
19. Gadd45gamma expression is reduced in anaplastic thyroid cancer and its reexpression results in apoptosis.
Chung HK; Yi YW; Jung NC; Kim D; Suh JM; Kim H; Park KC; Kim DW; Hwang ES; Song JH; Ku BJ; Han HJ; Ro HK; Kim JM; Shong M
J Clin Endocrinol Metab; 2003 Aug; 88(8):3913-20. PubMed ID: 12915687
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor activity of non-nucleosidic reverse transcriptase inhibitors.
Landriscina M; Spadafora C; Cignarelli M; Barone C
Curr Pharm Des; 2007; 13(7):737-47. PubMed ID: 17346188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
